B Proteomics ApS: Financial statements 2025
CVR: 44269422
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
B Proteomics ApS (CVR 44269422) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 747,048 and a net result of DKK 212,153. Equity in the 2025 report amounted to DKK 258,710. The solvency ratio was 55.2%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 747,048
- Profit/Loss
- DKK 212,153
- Equity
- DKK 258,710
- Total Assets
- DKK 468,449
- Employees
- 2
Official annual report
How creditworthy is B Proteomics ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
B Proteomics ApS has published its interim report for the period August 30, 2023 – December 31, 2024.
As of February 1, 2025, Jakob Bunkenborg is registered as adm. dir. of B Proteomics ApS.
As of February 1, 2025, Angela Mc Ardle has stepped down as adm. dir. of B Proteomics ApS.
As of January 31, 2025, Jakob Bunkenborg has stepped down as director of B Proteomics ApS.
About B Proteomics ApS
B Proteomics ApS is a Danish company of the type Anpartsselskab based in Odense M, founded in 2023. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Jakob Bunkenborg. The company is owned by Bunkarde Holding ApS. According to the 2025 annual report, the company had an average of 2 employees. In 2025, the company reported a gross profit of DKK 747,048 and a net result of DKK 212,153. Equity in the 2025 report amounted to DKK 258,710.